By CHARLES LATHRAM, III, FACMPE
Fellow, American College of Medical Practice Executives | Published Author | Secretary/Treasurer, UT MGMA | Past President, TN MGMA
Two senators walked into a press conference.
One is a progressive Democrat from Massachusetts who has spent her career treating Wall Street like a piñata. The other is a Republican from Missouri who is approximately the last person on earth she would invite to Thanksgiving dinner. They do not carpool. They do not text. In the long and storied history of ideological opposites being photographed together, this one belongs in a museum.
They called it the Break Up Big Medicine Act.
And before you ask — no, this is not the setup to a joke. I checked.
Here is what the bill actually does, in one paragraph, because I promised myself I would not become a person who writes legislative summaries for a living:
It says a corporation cannot own your doctor, your pharmacy, your insurance plan, and the middleman who decides what your prescriptions cost — all at the same time. It gives regulators and state attorneys general the teeth to force divestitures. It puts a one-year clock on compliance and attaches real penalties to missing it. It points directly at companies like UnitedHealth Group and CVS Health and says, with the full weight of bipartisan Senate backing: this structure is the problem.
That's it. That's the bill.
Whether it passes is a question for people who enjoy being disappointed professionally. I have other interests.
What I am actually interested in is what it means that this happened at all.
Washington is a lagging indicator. This is not an opinion. This is observable fact, confirmed by anyone who has spent more than fifteen minutes watching how policy actually moves. By the time something becomes a bipartisan bill with a name dramatic enough to be a Netflix documentary, the underlying reality has been sitting in plain sight for years — obvious to every practitioner, every patient, every administrator who has watched the consolidation machine do its work and wondered when someone with a microphone would say what everyone already knew.
Independent physicians didn't need this bill to understand the problem. They could see it in their referral patterns. They could feel it the moment the acquisition closed and the administrative apparatus arrived with its clipboards and its compliance trainings and its very sincere commitment to putting patients first, effective Q3.
The argument was not lost on the people living it.
What changed on February 10th is that the argument got said out loud — in the United States Senate, by two people from opposite ends of everything, with cameras rolling and C-SPAN doing whatever C-SPAN does.
The consolidation model is no longer being defended as inevitable progress. It is being named, by name, as the villain. That's new. That matters. Not because Warren and Hawley wrote a perfect bill — they didn't — but because the narrative just shifted and narratives, once shifted, are very difficult to shift back.
Here is what thirty years in this industry has taught me about moments like this one:
The industry doesn't respond to being wrong. It has been wrong for decades and responded by buying more practices.
It responds to being a political liability.
The patient who waited three months for an appointment is starting to connect that wait to the acquisition announcement in the local paper. The employer writing a $28,000 check for family coverage is starting to ask who decided that was reasonable. The senator facing a midterm election in November is starting to notice that healthcare consolidation is the rare issue that makes both the progressive base and the Trump voter equally furious — for exactly the same reasons.
The machine is not broken. It is working exactly as designed. That's why people are angry. And angry people vote.
So here is my completely non-policy-wonk take on what independent medicine should do with this moment:
Not wait for the bill to pass. It probably won't, not in its current form, not in this Congress, not through a subcommittee chaired by a senator who has historically viewed aggressive antitrust intervention with the enthusiasm most people reserve for a root canal.
Not dismiss it either. A bill that names your opponent's business model as a federal problem is not nothing, even if it never gets a floor vote.
What to do instead is what you've been doing. Keep practicing medicine the way it's supposed to be practiced. Keep saying out loud — to patients, to colleagues, to anyone in your state legislature who will sit still long enough to listen — that the independent model produces better outcomes and the data is not ambiguous. Keep being the proof that the alternative exists.
Because here's the thing about Washington finally catching up: it only catches up to arguments that have already been made, loudly and consistently, by people who knew the truth before the press conference was scheduled.
You knew. You've been saying it. The senators just arrived.
They're a little late. Welcome them anyway.
Charlie Lathram writes The Independence Playbook at independentdoc.org. He is not a policy wonk. He has said this clearly, repeatedly, and in writing. He is also, through a sequence of events he is still reconstructing, the Legislative Liaison for Utah MGMA — a role that requires him to track exactly the kind of bill he just told you he doesn't track. The universe, it turns out, has a sense of humor.